• linkedin
  • Increase Font
  • Sharebar

    Urology FDA approvals of 2016


    SEEit prostate magnetic resonance imaging solution

     

     

    Noninvasive prostate MRI system improves lesion conspicuity

    Siemens Healthcare received FDA clearance for its noninvasive SEEit prostate magnetic resonance imaging (MRI) solution. SEEit uses high-channel surface coils, providing a noninvasive image technique that improves lesion conspicuity in diffusion-weighted imaging with Siemens’ RESOLVE technology, the company says. It offers improved patient set-up and accelerated scans to help optimize process efficiency. Powered by syngo MR E11 software architecture, SEEit gives users high-performance MAGNETOM Aera 1.5 Tesla and MAGNETOM Skyra 3T MRI systems that can perform a routine prostate exam in just 10 minutes without using an endorectal coil. Use of Direct RF and high-density coil technology Tim 4G and RESOLVE technology delivers the essential signal-to-noise ratio and resolution that enable users to perform prostate MRI using only the company’s new Body 30/60 surface coil, according to Siemens.

    For more information, visit www.usa.siemens.com/prostatemri.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results